Menu

La Jolla Pharmaceutical Company LJPC

Full chart Compare
Set alert

Price alert · LJPC

All alert types
6.19 0.00 (+0.00%)

At closeAug 15, 2022, 4:00 PM EDT

6.19 Day range 6.22

52-week range unavailable

Revenue & Expenses

Revenue by
Product → Revenue: $43.53MRevenue → Gross Profit: $62.23MGross Profit → Net Income: $19.66MGross Profit → Selling, General & Admin: $35.39MRevenue → Cost of Revenue: $13.49MGross Profit → Research & Development: $5.01MGross Profit → Other Expenses: $2.12MGross Profit → Income Tax: $49.00KLicense And Other Revenue → Revenue: $32.19MGross Profit$62.23MCost of Revenue$13.49MNet Income$19.66MSelling, General & Admin$35.39MResearch & Development$5.01MOther Expenses$2.12MIncome Tax$49.00KRevenue$75.72MProduct$43.53MLicense And Other Revenue$32.19M

Latest period ending Dec 31, 2021 · select a line to chart its full history

LJPC annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
75.72M33.42M23.05M10.06M0
62.23M25.60M20.66M8.41M0
21.83M-35.84M-109.80M-194.05M-115.43M
19.66M-39.42M-116.51M-199.47M-114.80M
0.58-1.44-4.30-7.85-5.41
LJPC annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
46.71M21.26M88.73M173.51M91.82M
101.23M72.24M132.25M204.29M119.54M
167.97M160.33M188.24M168.37M31.34M
2.64M536.00K29.25M00
-66.74M-88.09M-55.99M35.92M88.20M
LJPC annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
28.24M-37.64M-84.95M-152.37M-85.08M
-9.00K-30.95M-698.00K-2.34M-9.19M
-2.79M1.12M864.00K236.40M120.17M
-9.00K3.07M-698.00K-2.34M-9.19M
25.45M-67.47M-84.78M81.69M25.90M